Trial intelligence / Profile preview

Niacin and Fenofibrate for Atherogenic Dyslipidemia in Obese Females

NCT03615534Phase 4Completed

Start
Oct 2014
Primary completion
Jun 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of fenofibrate, niacin in atherogenic dyslipidemia (AD). Started Oct 2014; status: completed.

02

Drugs

fenofibrateniacin
03

Conditions

atherogenic dyslipidemia (AD)

Beyond the preview

Go deeper on NCT03615534.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03615534.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call